Business Wire

Square Launches Integrated, Omnichannel Solutions For Businesses in France

21.9.2021 10:00:00 EEST | Business Wire | Press release

Share

Today Square, the globally trusted software, payments, and hardware solution for businesses of all sizes, launches in France. Following a successful Early Access Programme, now small businesses and large enterprises across France can access Square’s innovative ecosystem with the tools they need to start, run, grow, and adapt their businesses.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005137/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Square Launches Integrated, Omnichannel Solutions For Businesses in France (Photo: Business Wire)

“I’ve been using Square’s products both on-site and online over the past few months and it has revolutionised how I run my business,” said Anne-Laure Fonrose, Founder of Tatie Nanna. “Having an integrated, omnichannel payment solution means our customers can pay in any way that suits them. It’s all been easy to set-up and run, the product looks great on site, and the connectivity is super-fast which helps avoid long queues. I’m proud to be using Square as we continue to grow our business.”

French businesses will now have access to a full stack of integrated business tools. Square’s suite of products are designed to seamlessly work with each other to save businesses time and money, reduce inefficiencies from managing multiple systems, and help sellers grow their businesses in the future. Additionally, Square offers fair, transparent, and merchant-friendly pricing for business software and payment processing without requiring any long-term contract or extra fees. Square takes care of fraud prevention, dispute management, security, and compliance at no additional cost. Square’s POS certification also enables merchants to comply with the “Loi anti-fraude TVA, 20181”. Businesses can access their funds as soon as the next working day and only pay a transaction fee when they accept a card or mobile payment.

“International growth has been a key priority this year, and we’re proud to officially launch in France as our third European market,” said Alyssa Henry, Executive Vice President at Square. “Sellers around the country will now be able to use our omnichannel ecosystem of products and services, allowing business owners to focus on running their business.”

“We are thrilled to expand Square’s solutions into France, helping merchants to run their entire business end-to-end with integrated software, hardware, and data analytics, while making it easier for them to take card payments,” said Jason Lalor, European Executive Director at Square. “French businesses can trust Square to be a fair, transparent, and innovative partner they can rely on to help them run their business and get back-on-track after times of uncertainty.”

French businesses can now sell online, in-person, or both with Square’s integrated suite of products, including:

  • Point of sale and payments software and hardware to suit any business: Square launches with two point of sale software products and three versatile payment terminals in France offering both mobile and brick & mortar businesses fully integrated POS software, reliable and secure payments acceptance, and one transparent processing rate of 1.65% for all card-present transactions. With no long-term contracts or monthly fees, the systems are designed for you and your employees to get started quickly.
    • Square Point of Sale is the trusted solution used by business owners around the world to process payments, sell anywhere, and manage their customer base. With fast checkout flows, built-in customer management, and intuitive sales reporting, Square Point of Sale makes it easy to run a business customers love.
    • Square for Restaurants helps businesses by offering an integrated set of industry-specific tools and POS for food and beverage merchants that would ordinarily require multiple vendors, all under one umbrella.
    • Square Terminal, Square Stand, and Square Reader are versatile, easy-to-set-up devices. For a limited time, Square Terminal will be priced at 99 € (usually 165 €), Square Stand will be 79 € (usually 139 €), and Square Reader will be completely free (usually 19 €) – all available on Square Shop. This pricing is limited to one device per merchant.
  • Square Online: Square’s fully integrated e-commerce platform that automatically syncs inventory and orders with any Square point of sale makes it seamless for any business to expand through omnichannel selling. Square Online supports sellers across a variety of verticals: from easily enabling click-and-collect for local business, to a QR code dining platform allowing diners to order and pay from their mobile device, to a full ecommerce website with social media integrations for retail. Square Online offers a feature-rich free plan as well as a variety of paid subscription plans and payment processing is competitively priced at 1.4% + 25c per transaction for EU cards.
  • Robust business tools to power operations: Square manages the behind-the-scenes details, giving time back to merchants to focus on running their business. Tools include:
    • Online Checkout, to quickly sell online via embeddable buy buttons and payment links
    • Virtual Terminal, to use your computer to take payments remotely
    • Team Management, to streamline timecards and staffing
    • Kitchen Display System, to expedite your kitchen operations – including delivery orders
    • eGift Cards, to provide an additional way to reach customers
    • Square Invoices will launch later this year to help businesses send professional, digital estimates and invoices and get paid faster
    • Partner platform to unlock even more functionality: Square integrates with business tools like Prestashop, Wix, Bookeo and Deliverect to enable businesses to use Square seamlessly with third-party software that caters to their specific needs.
    • Suite of API’s enabling developers to create solutions for sellers: Our APIs and SDKs enable developers to build custom applications that can seamlessly integrate with the rest of our ecosystem of products.

Businesses interested in learning more about getting started with Square can visit: https://squareup.com/fr

About Square, Inc.

Square, Inc. (NYSE: SQ) builds tools to empower businesses and individuals to participate in the economy. Sellers use Square to reach buyers online and in person, manage their business, and access financing. Individuals use Cash App to spend, send, store, and invest money. And TIDAL is a global music and entertainment platform that expands Square's purpose of economic empowerment to artists. Square, Inc. has offices in the United States, Canada, Japan, Australia, Ireland, Spain, Norway, and the UK.

www.squareup.com

1On 24 October 2018, the French Anti-Fraud Act1 (loi relative à la lutte contre la fraude, the Act) was published in the Official Journal (OJ). The Act was designed to strengthen the measures to fight against taxpayers’ failure to comply with their tax and social duties.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Daniela Karthaus
00353-896025037
press@squareup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye